Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia (ozanimod) Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis

  • Home
  • 2021
  • May
  • 23
  • Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia (ozanimod) Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis

Original Source

On May 23, 2021

Post navigation

Previous PostBristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy
Next PostDollar General Publishes Annual Serving Others Report

Related Post

August 12, 2022
  • Business News

Modification to the Methodology of the S&P ESG Leaders Indices

August 12, 2022
  • Business News

Modification to the Methodology of the S&P Carbon Control Index Series

August 12, 2022
  • Business News

MACOM Technology Solutions Holdings Set to Join S&P MidCap 400

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219